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INTRODUCTION
Acute stroke is one of the major cause of morbidity and mortality. It 
can be arterial or venous in origin. Venous infarction, compared to arterial 
stroke, is less common, potentially treatable and so has a good prognosis.
Cerebral  venous  thrombosis  is  not  an  uncommon  disease.  The 
presenting signs and symptoms  of cerebral venous sinus thrombosis is so 
vague and diverse that it is referred to as `The Great Masquerador of diseases'.
Without CT or MRI many cases would be missed since the clinician is 
unsuspected of this disease. With the widespread availability of CT and MRI, 
and  the  awareness  of  this  pathology  among  general  physicians   and 
obstetricians,  the  rate  of  diagnosis  of  this  disease  has  increased  manifold 
during the last two decades.
Many  a  times  cerebral  venous  thrombosis  is  unsuspected  by  the 
treating clinician that the disease is first diagnosed by the radiologists.
It  is  important  on  the  part  of  the  radiologist  to  promptly  diagnose 
cerebral venous thrombosis since with early treatment the pathology is almost 
completely reversible and so has a very good prognosis.
Catheter  angiography  is  the  gold  standard  for  diagnosing  venous 
thrombosis.  But  the  preferred  modalities  are  CT and  MRI  since  they  are 
noninvasive, cheap and with little risk to the patient.
Conventional  CT,  with  and  without  contrast,  is  a  good  first 
investigation for patients with any CNS signs and symptoms. More than 80% 
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of Cerebral venous thrombosis can be diagnosed with this. It is also useful in 
ruling out intracranial tumors and infections.
MRI  and  MRV are  more  sensitive  than  CT in  diagnosing  cerebral 
venous  thrombosis.  It  can  also  map  the  extent  of  thrombosis  and 
parenchymal lesions.  With certain criteria MRI can also give a prognostic 
valuation of the disease.
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CEREBRAL VENOUS SINUS THROMBOSIS - A SYNOPSIS
ANATOMY
The cerebral venous system consists of 
(i) Superficial cortical veins.
(ii) Deep medullary and subependymal veins
(iii) Dural venous sinuses
Dural Venous Sinuses
The dural venous sinuses are interlinked large venous channels of the 
brain. They drain the veins of brain through superficial cortical veins  and 
deep veins. They ultimately drain via the internal jugular veins. The sinuses 
are endothelium lined venous channels formed between the superficial and 
deep layers  of the duramater (Gray's  Anatomy).
The superior sagittal sinus is an unpaired, midline, sagittaly oriented 
sinus. It lies at the base of falx cerebri. It drains the cortical veins of cerebral 
convexity.  It  extends from crista  galli  anteriorly  to  the  venous confluence 
posteriorly, where it joins the straight sinus and the two lateral sinuses.
The lateral sinuses are paired sinuses one on either side. It consists of 
two parts, the transverse and sigmoid sinuses. The transverse sinus lies at the 
base of tentorium from the  venous confluence upto the sigmoid sinus.
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The  sigmoid  sinus  lies  at  the  posterolateral  wall  of  the  petrous 
temporal bone, continuous with the transverse sinus and exiting the jugular 
foramen as internal jugular vein.
The inferior sagittal  sinus lies at the free margin of falx cerebri.  It 
drains into the straight sinus. Since it is thin, it in inconsistently imaged. 
The  Great  cerebral  vein  of  Galen  is  formed  by  the  basal  veins  of 
Rosenthal and the internal cerebral veins. It lies below the splenium of corpus 
callosum. Along with inferior sagittal sinus it forms the straight sinus.
The straight sinus lies at the confluence of falx cerebri and tentorium 
cerebelli. It courses posteroinferiorly and reaches the confluence of sinuses.
The cavernous  sinuses are paired sinuses on either side of pituitary 
fossa.  It  is  multiseptated  and  interconnected  venous  sinus.  It  receives  the 
superior  and inferior  ophthalmic veins.  It  is  closely  related to  ICA which 
courses within it. It is also associated with cranial nerves, III, IV, V1, V2 and 
VI which lie along its wall.
The  superior  and  inferior  petrosal  sinuses  are  small  inconsistently 
imaged sinuses.
Superficial Cortical Veins
The  superficial  cortical  veins  lie  on  the  convexity  of  cerebral 
hemispheres.  They are  very  variable  in  position  and distribution.  Most  of 
them run upward and join the Superior sagittal sinus.
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 Much of them are unnamed except.
(i) Vein of Labbe which runs from the sylvian fissure to the 
transverse sinus.
(ii) Vein of Trollard which runs from the sylvian fissure to  the 
superior sagittal sinus.
(iii) Superficial middle cerebral vein, which runs along the sylvian 
fissure.
In most angiograms one or other of these veins are visualized not all.
Deep cerebral veins 
The deep cerebral veins consist of
(i) Medullary veins in the depth of cerebral hemispheres.
(ii) Subependymal veins lying near the lateral ventricles receiving 
the medullary veins.
(iii) Basal veins draining the temporal lobes which  arises above the 
sella courses posteriorly round the midbrain
(iv) Internal  cerebral  veins  formed  by   thalamostriate  and  septal 
veins. They lie one on either side of midline. They commence 
just  behind  the  foramen  of  Monro  pass  in  the  roof  of  3rd 
ventricle lying in the telachoroidea.
Normal Anatomic variations
Like the variations of anatomy of lower limb veins, the cerebral veins 
also show many normal variations.
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The common variations are
(i) Asymmetry  of  transverse  sinus  with  right  sided  dominance 
being  most frequent.
(ii) Agenesis of part or full of transverse sinus.
(iii) Hypoplastic rostral end of superior sagittal sinus.
(iv) Hypoplastic inferior sagittal sinus.
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CEREBRAL VENOUS THROMBOSIS
CAUSES
Any pathology that alters the Virchow's triads of flow, vessel wall and 
fluid blood physiology can cause thrombosis  (J.Van Gijn). Stroke in young 
adults accounts 30% of all cases. Among this 10% to 20% are due to CVT. 
(Nagaraja D.Sarma GR).
The various causes are (Karthikeyan, Vijay et al).
1. Idiopathic
2. Pregnancy & Puerperium
3. Local infections like mastoiditis.
4. Dehydration
5. Oral Contraceptive Pills
6. Local tumor extension eg. Meningioma.
7. Systemic infection.
8. Systemic tumor syndrome.
9. Trauma
10. Coagulopathies -  Antiphospholipid syndrome 
- Antithrombin III deficiency
 -  Factor V Leiden mutation
- Protein C/S deficiency 
- PNH
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10. Inflammatory bowel disease
11. Behcet's syndrome
12. Nephrotic syndrome
In  many  cases  of  CVT,  no  obvious  cause  is  detected  and  remains 
idiopathic in origin. Pregnancy and puerperium are associated with hormonal 
changes  that  are  procoagulant  in  nature.  Also during  delivery  dehydration 
may occur resulting in hemoconcentration.
 Local infections like mastoiditis cause inflammation of the vessel wall 
and  predisposes  to  thrombosis.  Dehydration  caused  by  diarrhea  is  an 
important  cause  for  CVT  in  our  settings.  Dehydration  cause 
hemoconcentration and thus sluggish flow predisposing to thrombosis. 
Tumors like  meningioma cause thrombosis by multiple factors. Large 
tumors cause pressure effect over adjacent sinus and cause flow disturbance. 
Also tumors may alter vessel wall by infiltration and cause thrombosis.
Systemic tumor syndrome and septicemia results in hypercoagulable 
state  and endothelial  damage resulting in  thrombosis.  Nephrotic  syndrome 
results in loss of anticoagulant protein in urine and increased procoagulant 
proteins in serum resulting in thrombosis.
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CLINICAL FEATURES
Cerebral  venous thrombosis  is  protean in  its  presentation making it 
very difficult to diagnose unless a high degree of suspicion is present. The 
presentation can be acute subacute, or chronic.
          The various signs and symptoms at presentation are (Appenzeller et al).
1. Headache - Most common, present in > 80% of cases
2. Seizures - Present in 35% - 40% of cases. It can be 
focal or generalised.
3. Focal neurological signs - 30% - 35%
4. Altered sensorium - 30%
5. Vomitting.
The headache associated may be classical thunderclap headache or the 
more common nonspecific  in  nature.  Headache may be caused by venous 
congestion, raised ICT, neuronal irritation, or SAH.
The  seizure  activity  can  be  focal  or  generalised.  It  is  caused  by 
increased neuronal excitability due to edema, hemorrhage, infarct or raised 
ICT.
The  focal  neurologic  deficits  can  be  hemiparesis,  paraparesis, 
monoparesis,  dysphasia,  blindness,  cranial   nerve  palsy  etc.   Intermittent 
fluctuating  hemiparesis is classical of CVT. Since the superior sagittal sinus 
thrombosis  leads  to  bilateral  parasagittal  infarcts,  spastic  paraplegia  may 
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occur. Involvement of cavernous  sinus results in palsy of cranial nerves III, 
IV, V & VI.
The severity of altered sensorium  lies between confusion to coma. It 
implies   deeper  parenchymal  involvement.  Since  sudden  confusion  state 
which is unexplained by any pathology may be the only presenting symptom, 
CVT may be mistaken for psychiatric disorder.
Cavernous  sinus  thrombosis  results  in  painful  ophthalmoplegia, 
chemosis  and  proptosis.  Cerebral  venous  sinus  thrombosis  can  extend 
retrogradely into the cortical veins causing venous infarcts. 
The signs and symptoms of cerebral venous thrombosis may mimic 
arterial  stroke,  intracranial  tumors,  intracranial  infection,  subarachnoid 
hemorrhage, or psychiatric disorders.
Mortality and Morbidity
The mortality rate ranges from 10% to 15%. The mortality is usually in 
the acute stage. The cause being involvement of brainstem, deep parenchyma, 
transtentorial herniation due to mass effect.
The  residual  deficit  rate  lies  between  6%  to  20%.  The  focal 
neurological  deficits  at  admission  may  or  may  not  be  reversible.  Simple 
edema and venous congestion, compression due to mass effect may reverse 
with  treatment.  Venous  infarcts,  parenchymal  hematoma  and  secondary 
ischemic  necrosis  results  in  permanent  neuronal  damage  and  deficits. 
Depending on the region of brain involvement the deficits can be hemiparesis, 
monoparesis, paraparesis, blindness, cranial nerve palsy or dysphasia.
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DIAGNOSIS
Since the diagnosis of cerebral venous thrombosis is often missed by 
an unsuspecting clinician, radiological diagnosis remains an important part in 
its management.
The various modes of investigations are 
1. CT - Nonenhanced and contrast enhanced.
2. MRI - T1WI, T2WI, FLAIR, GRE, MRV, DWI.
3. Catheter Angiogram.
4. Others.
COMPUTED TOMOGRAPHY
The first investigation to be undergone by a patient with CNS signs 
and symptoms is CT. CT helps in diagnosing > 80% of cases of CVT. CT 
plays an important role in ruling out intracranial abscess or tumors.
The various signs  of CVT in CT are.
1. Hyperdense triangle sign -  Showing the thrombus within the 
superior sagittal sinus in NECT.
2. Cord sign - Dense cord like thrombosed cortical veins.
3. Empty Delta sign - In CECT the nonenhancing thrombus within 
the  superior  sagittal  sinus  is  surrounded  by  enhancing 
collaterals. This is seen as an empty delta.
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4. Parenchymal  hemorrhage  -  Due  to  venous  congestion  and 
venous infarction parenchymal hemorrhage occurs. The typical 
location is subcortical region.
5. Parenchymal hypodensity  -  This  is  due to  venous congestion 
edema or infarction. The edema is highly reversible whereas the 
infarct is not. The infarct is classically of non arterial territory, 
and  involves  bilateral  convexity  or  bilateral  basal  ganglia  / 
thalami.
6. Increased tentorial enhancement  due to venous congestion.
False  positive  empty  delta  sign  is  seen  in  high  splitting  tentorium, 
subdural hematoma, subdural empyema.
NECT is an highly sensitive tool for intracranial hemorrhage which is 
a common finding in CVT.
Recently, using MDCT, venogram of intracranial venous system can 
be acquired (Karthikeyan, Vijay et al). Contrast enhancement with scanning 
in the venous phase is done. CT venogram is then reconstructed using MIP 
and MPR projection. This is highly sensitive and can be comparable to MRV. 
But the use of CT venogram is not used widely at present.
CATHETER ANGIOGRAM
Catheter angiogram can be done either conventionally or using DSA 
technique. The venous phase of angiogram is taken. Aortic arch injection of 
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contrast is done to simultaneously  opacify all the four vessels of cerebral 
circulation. This avoids unopacified blood mimicking a clot within the sinus.
The thrombosed sinus  appears  as  empty channel  devoid of  contrast 
surrounded by collaterals. Thrombosed cortical veins are seen as intraluminal 
filling defects and in delayed phase as cord of contrast collection. Since CT & 
MRI are sensitive and specific in CVT need of catheter angiogram is obviated 
(Laffile, Bourkobaz et al).
MRI AND MRV
T1WI, T2WI, FLAIR, T2*WI MRV & DWI are used in diagnosis of 
sinus thrombosis and the parenchymal changes.  FSE and GRE sequences are 
used. These sequences can directly visualise the thrombus within the venous 
sinus and are also sensitive in detecting the parenchymal lesions of edema, 
hemorrhage and infarcts.
Thrombosis in Sinuses
2D TOF MRA technique is used for venogram of  cerebral sinuses. Time 
of  flight  phenomenon  of  flow  related  enhancement  in  used.  Inflow  of 
unsaturated spins in blood gives more signal when compared to the partially 
saturated stationary protons. Using post processing venograms are obtained. 
2D TOF MRA is sensitive to slow flow. Coronal and oblique section may be 
taken. 
The thrombus within the sinus can be imaged with T1 & T2 weighted 
images or with MRV. In T1 & T2 weighted images the normal venous sinus 
18
shows flow void due to moving blood. In thrombosed sinuses the flow void is 
absent  with  varying  signal  depending  on  the  age  of  thrombus  and  the 
sequences used.
In acute stages (First 3 to 5 days) the thrombus appears isointense in T1 
&  T2.  During  the  subacute  phase  (5  to  30  days)  the  thrombus  appears 
hyperintense in T1 & T2 images. It should be noted that recanalisation occurs 
in later stages which alters the signals from thrombus and a flow void may be 
present.
In 2D TOF MRV the slow flowing venous blood is imaged and canbe 
inspected  as  source  image  and  MIP  images.  Absent  signal  with  frayed 
appearance is  a  feature  of  thrombosis.  Hypoplastic  venous  sinus,  in  plane 
effect, slow flow are some artefactual conditions for false positive finding. So 
a careful analysis of source images and T1, T2 sequences is mandatory. So 
also thrombus may have hyperintense signals in MRV mimicking flow. Use 
of contrast and evaluation of T1,T2 images clarify these queries.
The parenchymal  edema appears  hyperintense in  T2WI and FLAIR 
images. Venous infarcts appear hyperintense in T2 WI and FLAIR images. It 
is  differentiated  from  edema  by  DWI  which  shows  hyperintense  regions. 
Venous infarcts often show hemorrhage.
Hemorrhage
Hemorrhage  can  be  intraparenchymal   or  in  subarachnoid  space. 
Intraparenchymal hemorrhage appearance in T1 and T2 images vary with the 
stage of hemoglobin breakdown. 
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Five  stages  of  evolution  of  hematoma  is  recognised  using  MRI 
characters on T1 & T2 weighted images (Bradley WG et al Gomori et al).
They are 1. Hyperacute  - < 24 hrs
2. Acute - 1 to 3 days
3. Early subacute - 3 to 7 days
4. Late subacute - 7 to 14 days
5. Chronic - > 14 days
In the hyperacute stage there is intracellular oxyhemoglobin. In the acute 
stage oxygen dissociate forming deoxyhemoglobin. During the subacute stage 
deoxyhemoglobin  is  oxidatively  denatured  to  methemoglobin  which  is 
intracellular in early subacute and extracellular in late subacute due to RBC 
lysis.  During the  chronic  phase heme is  digested by the  macrophages  and 
converted to hemosiderin  and ferritin.
The progression of hemoglobin catabolism within the hematoma starts in 
the periphery and extends into the centre. So at a point of time the hematoma 
consists of hemoglobin stages of varying ages. But the hematoma should be 
aged taking into account the most advanced stage of hemoglobin catabolism.
The  signal  intensities  of  the  hematoma  depends  on  age  of   the 
hematoma,  weightage  (T1  or  T2)   sequence  used  (FSE  or  GRE)  & field 
strength.
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The common pattern of signal intensities are
Sl.No Stages T1 T2
1. Hyperacute (oxyhemoglobin) ISO Hyper
2. Acute (Deoxyhemoglobin) ISO/Hyp
o
Hypo
3. Early Subacute 
(Intracellular methemoglobin
Hyper Hypo
4. Late Subacute 
(Extracellular methemoglobin)
Hyper Hyper
5. Chronic (Ferritin, hemosiderin) Hypo Hypo
GRE sequences are more sensitive to hemorrhage (Luxia Liang et al). 
Since the 180° refocusing pulse of spin echo sequence is replaced by gradient 
pulses,  the  susceptibility  is  increased.  Hemoglobin,  because  of  its 
susceptibility  effect  causes  signal  loss  of  adjacent  protons  and  appears 
hypointense. 
FLAIR  sequence  is  highly  sensitive  for  subarachnoid  hemorrhage 
(Rohit Bakshi et al). FLAIR is basically T2 image with suppression  of free 
water  protons.  So  the  CSF is  suppressed  and  hypointense  in  nature.  This 
results in increased visibility of blood in subarachnoid space.
OTHER INVESTIGATIONS
Quantitative  analysis  of  D-  dimer  in  blood  is  done.  This  is  a 
breakdown product of the thrombus. It is increased in the serum when there is 
venous thrombosis. A measurement of > 500 ng / ml is highly suggestive of 
CVT. It  has a  sensitivity  of  83% and specificity of  90%  (Lalive PH, 
Demoorloose et al) . It is a useful screening modality.
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TREATMENT
The  management  of  CVT  consists  of  symptomatic  treatment  and 
definitive treatment of the thrombus.
It consists of (i) Antiepileptics
(ii) Treatment of raised ICT
(iii) Antithrombotics
(iv) Treatment of primary cause.
Seizure is a poor prognostic factor. It results in secondary ischemia and 
brain  damage.  So  control  of  seizures  using  antiepileptics  both  oral  and 
parenteral remain one of the mainstay in CVT treatment.
CVT results in venous congestion, parenchymal edema, hemorrhage 
and infarcts.  These  results  in  raised  ICT.  This  can  result  in  transtentorial 
herniation  of   brain  parenchyma  and  brainstem   compression  leading  to 
sudden  death.  So  prompt  treatment  of  raised  ICT  prevents  much  of  the 
mortality associated with CVT. Treatment consists of medical and surgical 
methods.  Medical  management  includes  IV  mannitol.  Surgical  treatment 
includes  burrhole  decompression  of  cranium,  hemicraniectomy,  surgical 
debridement (Jam Stom et al).
Heparin  remains  the  firstline  treatment  of  CVT (Marie Germaine 
et  al).  Recent  studies  show  its  safety  even  in  hemorrhagic  lesions.  It  is 
followed by oral anticoagulants for atleast 12 months.
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Local thrombolysis is reserved for those who donot respond well to the 
above treatment. Local urokinase infusion into the thrombosed sinus results in 
lysis of thrombus. It  can be done through internal jugular or femoral vein 
routes.  rtPA  is  a  good  alternative  for  urokinase.  Complication   include 
increased intracranial bleed and pelvic bleed from the puncture site.
Mechanical disruption of clot can be done using various mechanical 
devices. In case of deep vein thrombosis and cerebellar  infarction ventricular 
drainage is used to relieve hydrocephalus.
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AIM OF THE STUDY
1. To evaluate the findings of  cerebral  venous sinus thrombosis 
using T1W, T2W, FLAIR,  diffusion weighted images, and MR 
venogram.
2. To evaluate the prognosis  by using restriction of diffusion in 
diffusion weighted images.
3. To evaluate the prognosis using T1WI, T2WI, FLAIR and MR 
Venogram.
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REVIEW OF LITERATURE
1. Roettger C., Trittmache S., Gerriels T. Kops, Stolz E.
15 patients with proven CVT and parenchymal lesions were followed 
up for 12 months. The one month follow up MR shows correlation of volume 
of lesion with recanalisation whereas 12 months followup didnot show this 
correlation of lesion volume and early recanalisation.
This implies that early lesions consist of both edematous and infarcted 
regions. Edema recovers early with recanalisation whereas the infarcts persist 
even after 12 months.
2. Wassay M., Azeemuddin M.
Diffusion weighted images are extremely sensitive in differentiating 
cytotoxic edema from vasogenic edema. Cytotoxic edema shows restricted 
diffusion appearing hyperintense in DWI.
3. Mullins ME, Grants PE, Wang B Gonzalez RG, Schoefer PW
13  patients  were  evaluated  of  which  10  showed  parenchymal 
hemorrhagic lesions. Seven lesions showed increased diffusion (ie) vasogenic 
edema that resolved. 
Three lesion had decreased diffusion but resolved in follow up images. 
Four lesions which were diffusion restricted persisted in  follow up scans. 
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This  implies  all  lesions  with  increased  diffusion  and  a  significant 
number of lesions with restricted diffusion are reversible with treatment.
4. Imada, Ikowa, Kavamoto et al
A case report of 37 yr old male patient with CVT and deep grey matter 
hyperintense lesion. The lesion showed no restriction on DWI.
With conservative management the follow-up MRI showed reversal of 
the  lesion and complete recovery.  MRI with DWI predicts  reversibility  of 
lesion when there is no diffusion restriction.
5. Sarma D., Farb RI et al
A  case  report  of  extensive  CVT  and  parenchymal  lesions  with 
restricted diffusion in DWI.
On follow up MRI there was complete reversal of the lesion implying 
some  lesions  with  restricted  diffusion  are  also  completely  reversible  with 
treatment.
6. Milan, Garcia, Vila N. et al
A case  report  of  CVT with  deep  parenchymal  lesions.  The  lesions 
showed no restriction in DWI.
The  lesions  completely  recovered  in  followup  scan  implying  the 
reversibility on vasogenic edema. 
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7. Wassay M. Bakshi et al
The  authors  reviewed  3  cases  with  CVT.  Two  patients  showed 
hyperitensity  in  DWI  implying  cytotoxic  edema  and  one  showed 
hypointensity showing vasogenic edema.
8. Favrole, Guichard, Crossland I et al
28 patients with CVT were evaluated for diffusion within the clots. It 
was observed that restricted diffusion within the clot is a predictor for poor 
recanalisation in followup scans.
9. Ducreax, Oppenheinm C et al
Seven patients with CVT and T2 hyperintensities were evaluated with 
DWI. Five patients had hypointensity in DWI and recovered completely two 
had restricted diffusion of which one recovered and one had sequelae.
This study shows lesions with normal diffusion are reversible. Lesions 
with diffusion restriction are reversible in some and persist in some patients.
10. Appenzeller S et al
Twenty four patients with CVT presented with following symptoms
- Headache - 75% 
- Vomitting - 33%
- Altered Sensorium - 21%
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Probable causes were
- Pregnancy / Puerperium - 25%
- OCP - 17%
- Trauma - 8%
This study also showed CT to have a false negative rate of 37%
11. Oumurciuc R et al
This  study  with  17  patients  with  isolated  headache  as  presenting 
symptom showed lateral sinus involvement being most common.
12. Canhao P; Ferro JM et al
A multinational  prospective  study including 624 patients  with CVT 
and evaluation of the causes for death in the acute phase.
Mortality  rate  was  3.4%  within  1  month.  Causes  of  death  were 
transtentorial herniation and multiple lesions. Independent predictors of death 
were  coma,  altered  sensorium,  deep  CVT,  right  sided  hemorrhage,  and 
posterior fossa lesions.
13. Stolz, Rahimi, Gerrits et al
The authors analysed 79 patients with CVT for causes of death.
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The  significantly  related  factors  are  age,  neurologic  deficit  at 
presentation,  more  than  2  seizures  even  with  treatment,  venous  infarct, 
hemorrhagic lesions.
14. Karthikeyan D. S.Vijay T Kumar, Ikanth.
Their observation showed the presenting symptoms as 75% with focal 
deficit and headache, 30% - 50% with seizures, 18% - 38% with benign ICT 
symptoms. Mortality rate of 10% - 80% and morbidity rate of 6% - 20%.
15. Breteau, Mourier, Vehier et al
3 years follow up of 55 patients showed 45 patients independent and 
10 patients either dead or dependent.
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MATERIALS AND METHODS
Out study is a prospective cohort study of 48 patients carried out at 
Barnard Institute of Radiology, Madras Medical College, Chennai between 
Feb 2004 Jan 2006. All the 48 patients were subjected to MRI & MRV. MRI 
was performed using 1.5 Tesla super conducting SIEMENS MAGNETOM, 
SYMPHONY using head coil.
 Method
The patient is placed in supine position in the MR gantry with head 
coil positioned.
MR Techniques
Multiplanar scout sections obtained for planning the sequences. Whole 
brain MR from vertex to the foramen magnum including the base of skull are 
taken using axial coronal and sagittal sections.
The sequences used were.
T1WI Sagittal T2WI Axial
TR - 500 msec   S/G - 5/1.5 TR - 4000 msec  S/G - 5/1.5
TE - 14 msec TE - 93 msec
FLAIR Axial T2WI Coronal
TR - 9000 msec S/G - 5/1.5 TR - 4000 msec  S/G - 5/1.5
TE - 105 msec TE - 93 msec
DWI Axial GRE T2* Axial
TR - 4300 msec  S/G - 5/1.5 TR - 839 msec   S/G - 5/1.5
TE - 123 msec TE - 27 msec
b=0, 500, 1000
MRV - 2D TOF MRA - 3D TOF
TR - 30 msec TR - 41 msec
TE - 6.5 msec TE - 6.8 msec
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All  the  patients  presented  with  CNS  signs  &  symptoms  some 
suspicious of CVT and others with vague features.
Inclusion Criteria
1. All  patients  confirmed  by  MRI  & MRV as  cerebral  venous 
sinus thrombosis.
2. Males and females are included.
3. All age groups included.
Exclusion Criteria
1. Patients with MR incompatible devices or implants.
2. Patients on life support systems.
3. Patients with claustrophobia.
The clinical features at admission were analysed concentrating on.
1. Headache,
2. Seizure - Focal or generalised
3. Altered sensorium, coma,
4. Focal  neurological   deficit  -  Hemiparesis  paraparesis, 
monoparesis,  CN palsy, blindness, dysphasia.
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MRI Findings
1. Hemorrhage - The age of the parenchymal hemorrhage whether acute, 
subacute, chronic is noted using T1W and T2W images. The site of hematoma 
whether  superficial  or  deep  is  noted.  The  presence  of  subarachnoid 
hemorrhage is noted using FLAIR images.
2. Thrombosis within Sinuses -  Using 2D TOF MRV, T1W and T2W 
images the thrombosis within the superior sagittal, inferior sagittal, straight, 
lateral sinuses are noted. Cortical vein thrombosis is identified.
3. T2 hyperintense lesion in superficial and deep cerebral regions.
T2 hyperintensities are due to prolongation of T2 time due to increased 
water protons. This increased water molecules can be either in extracellular or 
intracellular compartment.
Extracellular  water  is  due  to  interstitial  edema of  vasogenic  origin. 
Intracellular water is due to failure of membrane Na+ K + ATP ase due to 
decreased  ATP  since,  in  ischemia,  hypoxia  results  in  decreased  ATP 
production. Due to pump failure Na+ accumulate  intracellularly and along 
with it water molecules are trapped intracellularly.
T2 WI cannot differentiate these two types of edema.
4. Diffusion Restriction
Using DWIs and ADC map the sites of diffusion restriction and their 
extent are noted
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Time of  Flight Effect
When there is macroscopic proton  movement across a slice as in blood 
flow within a vessel, there is either flow void (SE Sequence)  or flow related 
enhancement (GRE Sequence).
The basic principle to this is that when a partially saturated proton is 
excited, the signal output is relatively less when compared with excitation of 
an  unsaturated   proton.  So  in  a  gradient  sequence  the  stationary  protons 
because of repeated excitation are partially saturated, whereas the unsaturated 
protons  that  flow  fresh  from  outside  the  slice  when  excited  gives  higher 
signal. This is known as flow related enhancement.
2D Fourier Transform  Gradient Echo TOF Technique in ideally used for 
MR venogram. Here sequential  multiple thin slices of image acquisition is 
done.  This  is  processed  using  2D  fourier  transformation.  2D  FT  TOF  is 
sensitive to slow flow. 3D TOF has the disadvantage of saturation of slow 
flowing blood.
Direct coronal or oblique scan section can be used so that the scan plane 
is perpendicular to the direction of blood flow. Using post processing MIP 
technique  MR venogram is  obtained.  Motion  compensation  gradients,  and 
short  echo  times  reduces  signal  loss  secondary  to  motion  induced  phase 
effect.
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Basic Principles
Bright Inflow Blood Signal
Background Tissue Suppression
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Basic principles
• Suppression of stationary tissue signal
• Generation of bright Blood flow signal
Image Slice
Relaxed Spins
Saturated Spins
Flow
Bright Inflow Blood Signal
Radio frequency (RF) pulse
Longitudinal Magnetisation Vector
Background Tissue suppression
Radio frequency (RF) pulse
.
Longitudinal Magnetisation Vector
Diffusion weighted images
DWI are a set of sequences in which an added gradient is applied to the 
protons apart from the normal slice selection, frequency and phase encoding 
gradients.
Water protons normally diffuse randomly in the fluid medium. They can 
be restricted by macromolecular proteins, membranes of organelles within the 
cell. Normal size of cell lies between 10 to 20 µm diameter.
In the  DWI sequence strong gradient dephasing pulse is first applied. 
Then after an interval of 40 to 50 msec another rephasing gradient pulse is 
applied. When the protons are stationary or restricted in diffusion during the 
interval of 40 msec they would not have diffused much distance and so the 
dephasing and rephasing  pulse cancel each other resulting in good signal 
output. 
When the protons are freely mobile the two gradients are not equally 
applied since the protons would have travelled across more distance. So there 
is partial saturation and so signal loss.
The time interval of 40 msec is  taken since the proton under normal 
body conditions would travel a distance of about 10 to 15 µm during this 
period and this is approximately the size of the human cell.
The gradient strength is increased so that the b values are 0, 500,1000 
The b value is directly proportional to the square of gradient strength. 
b =  γ 2 δ 2G2  (∆ - δ /3)
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At least two sets of images of varying b value are obtained and using 
mathematical  derivation   from  the  signal  from  each  voxel  the  apparent 
diffusion coefficient is obtained for each voxel.
This is given shades of gray and plotted as an image giving the ADC 
map.  When the protons are  freely mobile  there  is  complete loss  of  signal 
represented as hypointense signal  in the diffusion sequence with increased 
ADC depicted as hyperintensity in ADC map.
When the protons are restricted in diffusion there is hyperintensity in 
higher gradient images with decreased ADC and hypointensity in ADC map.
CT, both NECT and CECT were taken using 5 mm posterior fossa 
sections and 10mm supratentorial sections.
CT is analysed for.
1. Empty  delta  sign  -  This  is  due  to  non  enhancing  thrombus 
within  superior  sagittal  sinus  with  surrounding  enhancing 
collaterals in CECT.
2. Hyperdense Triangle sign - caused by dense thrombus within 
the superior sagittal sinus in NECT.
3. Cord sign of thrombosed cortical veins.
4. Presence of hemorrhage - Hemorrhage appears hyperdense in 
CT.  The  hemorrhage  is  usually  intraparenchymal  in  location 
with surrounding hypodensity. The hemorrhage can be due to 
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venous congestion or due to venous infarction. There can also 
be subarachnoid hemorrhage.
5. Hypodense lesion - Hypodense lesions of parenchyma can be 
superficial or deep. The hypodense lesions may represent either 
simple vasogenic edema due to venous congestion or an infarct. 
CT cannot differentiate the above two. The hypodense lesions 
are classically  bilateral and subcortical in location.
The patients were treated with
1. Supportive care
2. IV fluid
3. Anti edema measures - IV mannitol, IV steroids.
4. Parenteral heparin
5. Oral anticoagulants
6. Antibiotics, Vitamins
7. Surgical decompression
Follow up
Followup of all patients at 8 weeks was done. Poor outcome was defined 
as either death or focal neurological deficit at the end of eight weeks. In our 
study at the end of 8 weeks 3 patients were dead, all died  in the acute phase 
of the disease.  3 patients had hemiparesis,  one had paresis of right upper 
limb, and two had hemiparesis with dysphasia.
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OBSERVATIONS
Table 1 
AGE DISTRIBUTION
FOLLOWUP
AGE DISTRIBUTION
Total< 25 25 - 35 35 - 45 > 45
Count % Count % Count % Count % Count %
Normal 12 80 12 80.0 8 80 7 87.5 39 81.25
Deficit 3 20 1 6.7 2 20 6 12.5
Death 2 13.3 1 12.5 3 6.25
Total 15 100 15 100.0 10 100 8 100 48 100
There is no significant association between age of the patients and the 
prognosis.
38
< 25 25 - 35 35 - 45 > 45
0
2
4
6
8
10
12
14
16
Age Distribution
Death
Deficit
Normal
No
. o
f p
at
ie
nt
s
Table 2 
SEX  DISTRIBUTION
SEX
FOLLOWUP TotalNormal Deficit Death
Count % Count % Count % Count %
Female 28 71.8 5 83.3 2 66.7 35 72.9
Male 11 28.2 1 16.7 1 33.3 13 27.1
Total 39 100.0 6 100.0 3 100.0 48 100.0
There  is no significant association between sex of the patient and the 
prognosis.
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Table 3 
PUERPERIUM
FOLLOWUP
PUERPERIUM TotalNegative Positive
Count % Count % Count %
Normal 7 87.5 21 77.8 28 80.0
Deficit 5 18.5 5 14.3
Death 1 12.5 1 3.7 2 5.7
Total 8 100.0 27 100.0 35 100.0
Out  of  35  female  patients  27  were  puerperal  patients.  There  is  no 
significant association with prognosis.
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Table 4 
CLINICAL PRESENTATION - HEADACHE
FOLLOWUP
HEADACHE TotalNegative Positive
Count % Count % Count %
Normal 8 100.0 31 77.5 39 81.3
Deficit 6 15.0 6 12.5
Death 3 7.5 3 6.3
Total 8 100.0 40 100.0 48 100.0
40 (83.3%) patients out of 48 presented with complaints of headache.
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Table 5
CLINICAL PRESENTATION - SEIZURE
FOLLOWUP
SEIZURE TotalNegative Positive
Count % Count % Count %
Normal 27 87.1 12 70.6 39 81.3
Deficit 3 9.7 3 17.6 6 12.5
Death 1 3.2 2 11.8 3 6.3
Total 31 100.0 17 100.0 48 100.0
      
17 (35.4%) out of 48 patients had seizure at presentation.
There is  no statistically  significant association between headache or 
seizure with prognosis (P > 0.05).
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Table 6 
CLINICAL PRESENTATION - ALTERED SENSORIUM
FOLLOWUP
ALTERED SENSORIUM TotalNegative Positive
Count % Count % Count %
Normal 35 89.7 4 44.4 39 81.3
Deficit 4 10.3 2 22.2 6 12.5
Death 3 33.3 3 6.3
Total 39 100.0 9 100.0 48 100.0
      p < 0.01 (Chi  square test)
Nine (18.7%)  out  of  48 patients  presented  with  altered  sensorium. 
Out of  this  9 patients 5 had poor outcome which is statistically significant 
(p < 0.01).
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Table 7 
CLINICAL PRESENTATION - FOCAL 
NEUROLOGICAL DEFICIT
FOLLOWUP
DEFICIT TotalNegative Positive
Count % Count % Count %
Normal 30 88.2 9 64.3 39 81.3
Deficit 1 2.9 5 35.7 6 12.5
Death 3 8.8 3 6.3
Total 34 100.0 14 100.0 48 100.0
      p < 0.01 (Chi square test)
5  out  of  9  patients  who  presented  with  deficit  had  poor  outcome. 
Which is statistically significant (p < 0.01)
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Table 8 
CT - PARENCHYMAL HEMORRHAGE
FOLLOWUP
CT- PARENCHYMAL HEMORRHAGE TotalNegative Positive
Count % Count % Count %
Normal 33 94.3 6 46.2 39 81.3
Deficit 1 2.9 5 38.5 6 12.5
Death 1 2.9 2 15.4 3 6.3
Total 35 100.0 13 100.0 48 100.0
     p < 0.01 (Chi square test)
Presence of hemorrhage in CT is associated with poor outcome. This 
association is highly significant (p < 0.01).
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Table  9 
CT - SSS THROMBOSIS
FOLLOWUP
CT - SSS THROMBOSIS TotalNegative Positive
Count % Count % Count %
Normal 12 100.0 27 75.0 39 81.3
Deficit 6 16.7 6 12.5
Death 3 8.3 3 6.3
Total 12 100.0 36 100.0 48 100.0
Table 10
CT - LS THROMBOSIS
FOLLOWUP
CT - LS THROMBOSIS Total
Negative Positive
Count % Count % Count %
Normal 20 83.3 19 79.2 39 81.3
Deficit 3 12.5 3 12.5 6 12.5
Death 1 4.2 2 8.3 3 6.3
Total 24 100.0 24 100.0 48 100.0
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Table  11 
CT - STS THROMBOSIS
FOLLOWUP
CT - STS THROMBOSIS Total
Negative Positive
Count % Count % Count %
Normal 37 84.1 2 50.0 39 81.3
Deficit 5 11.4 1 25.0 6 12.5
Death 2 4.5 1 25.0 3 6.3
Total 44 100.0 4 100.0 48 100.0
      
       (p > 0.05 Chi square test)
There is no statistically significant association of thrombosis in CT 
with outcome (P > 0.05).
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Table 12 
CT - HYPODENSITY
FOLLOWUP
CT - HYPODENSITY TotalNegative Positive
Count % Count % Count %
Normal 36 92.3 3 33.3 39 81.3
Deficit 3 7.7 3 33.3 6 12.5
Death 3 33.3 3 6.3
Total 39 100.0 9 100.0 48 100.0
       p < 0.01 (Chi square test)
66% of patients with hypodensity had poor outcome when compared to 
7.7% of  patients  without hypodensity which has high statistical significance 
(p < 0.001).
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Table 13
MRI HEMORRHAGE
FOLLOWUP
MRI HEMORRHAGE TotalNegative Positive
Count % Count % Count %
Normal 27 96.4 12 60.0 39 81.3
Deficit 1 3.6 5 25.0 6 12.5
Death 3 15.0 3 6.3
Total 28 100.0 20 100.0 48 100.0
20 patients( 41.6%) presented with hemorrhage in MRI 8 patients out of 
this had poor outcome with high significance (p < 0.01)
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Table 14
MRI  - SSS THROMBOSIS
FOLLOWUP
MRI - SSS THROMBOSIS TotalNegative Positive
Count % Count % Count %
Normal 9 100.0 30 76.9 39 81.3
Deficit 6 15.4 6 12.5
Death 3 7.7 3 6.3
Total 9 100.0 39 100.0 48 100.0
Table 15
MRI  - LS THROMBOSIS
FOLLOWUP
MRI- LS THROMBOSIS TotalNegative Positive
Count % Count % Count %
Normal 12 80.0 27 81.8 39 81.3
Deficit 3 20.0 3 9.1 6 12.5
Death 3 9.1 3 6.3
Total 15 100.0 33 100.0 48 100.0
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Table 16
MRI  - STS THROMBOSIS
FOLLOWUP
MRI - STS THROMBOSIS TotalNegative Positive
Count % Count % Count %
Normal 34 89.5 5 50.0 39 81.3
Deficit 4 10.5 2 20.0 6 12.5
Death 3 30.0 3 6.3
Total 38 100.0 10 100.0 48 100.0
         p < 0.01 (Chi square test)
81.3% patients presented with SSS thrombosis, 68.7% presented with LS 
thrombosis.  No  significant  association  of  SSS,  LS  thrombosis  with  poor 
outcome.
20.8% patients had St.Sinus thrombosis. It is significantly associated 
with poor outcome (p < 0.01)
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Table 17
MRI  - T2 HYPERINTENSITY SUPERFICIAL
FOLLOWUP
T2 HYPER - SUPERFICIAL TotalNegative Positive
Count % Count % Count %
Normal 13 92.8 26 76.5 39 81.3
Deficit 6 17.6 6 12.5
Death 1 7.2 2 5.9 3 6.3
Total 14 100.0 34 100.0 48 100.0
       p = 0.24 (Chi square test)
There is no significant association of T2 hyper intensity in superficial 
parenchyma  with poor outcome 
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Table 18
MRI T2 HYPERINTENSITY DEEP
FOLLOWUP
T2 HYPER - DEEP TotalNegative Positive
Count % Count % Count %
Normal 38 97.4 1 11.1 39 81.3
Deficit 1 2.6 5 55.6 6 12.5
Death 3 33.3 3 6.3
Total 39 100.0 9 100.0 48 100.0
        p < 0.001 (Chi square test)
9 out of 48 patients had deep parenchymal hyperintensity of which 8 had 
poor outcome which shows a highly significant association (p < 0.01).
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Table 19
MRI - DIFFUSION RESTRICTION
FOLLOWUP
MRI-DIFFUSION RESTRICTION TotalNegative Positive
Count % Count % Count %
Normal 35 100.0 4 30.8 39 81.3
Deficit 6 46.2 6 12.5
Death 3 23.1 3 6.3
Total 35 100.0 13 100.0 48 100.0
        p < 0.001 (Chi square test)
Follow up is  highly associated with MRI diffusion (p < 0.001) all  9 
patients who had poor outcome had diffusion restriction.
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DISCUSSION
In our study done in  Barnard Institute  of  Radiology Madras Medical 
College, between Feb 2004 to Jan 2006 48 patients were included. All these 
patients were selected with MR evidence of cerebral venous sinus thrombosis.
The age range of the affected patients is 18 to 66 with a mean age of 33. 
There is no statistically significant association of age with poor outcome in 
our study as against the study of Stolz, Rahimi et al who showed increasing 
age to be a poor prognostic indicator.
The Male : Female sex ratio in our study is 1:2.7 that is, males form 27% 
of the patients.  This  shows that  CVT is  not uncommon among males and 
should be a differential diagnosis in any patient with suspicious CNS  signs 
and symptoms. Sex doesnot play a role in outcome of CVT in our study.
Among the 35 female  patients 21 were in puerperal period (ie) 60% of 
female  patients.  This  proves  that  puerperium  is  high  risk  for  CVT.  
The  outcome  among  puerperal  females  does  not  show  any  significant 
difference from the  nonpregnant female.
In the study of Appenzeller et al pregnancy, puerperium, OCP are good 
prognostic indicators.
In our study the percentage of presenting symptoms are
Headache - 83.3%
Seizure - 35.4%
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Altered Sensorium - 18.7%
Neurological Deficit - 29.1%
Among  these  presenting  symptoms,  altered  sensorium  and  focal 
neurologic deficit are statistically significant poor prognostic indicators with 
patients in coma related to death and focal deficit related to deficit at 8 weeks 
follow up. This is in agreement with the study of Appenzeller et al and Ferro,  
Canhao et al.
The number of patients with parenchymal hemorrhage detected by CT is 
13 out  of  which 7 had poor outcome.  It  is  found that  this  sign is  a  poor 
prognostic  indicator  with  P  <  0.01.  According  to  Ferro,  Canhao  et  al  
hemorrhage on admission CT is associated with poor outcome.
The incidence of thrombosis in CT are
Superior Sagittal Sinus - 75%
Lateral Sinus - 50%
Straight Sinus - 8.3%
There  is  no  significant   association  of  thrombosis  with  the  patient 
outcome.
The presence of parenchymal hypodensity in CT which can be either 
simple vasogenic edema or a venous infarct was found to be in 9 patients 
(18.7%) of which 3 died and 3 had deficit. This  has  a  highly  significant 
association  with  poor  outcome  with   P < 0.001.
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CT was normal in 9 patients ie 18.7% 
41.6% of patients had intraparenchymal hemorrhage detected by MRI. 8 
patients out of this had poor outcome. That is 8 out of the 9 poor outcome 
group had hemorrhage. This is a statistically significant association.
The presence of thrombosis detected by MRI are
Superior Sagital Sinus - 81.3%
Lateral Sinus - 68.7%
Straight Sinus - 20.8%
This corresponded with similar statistics in literature.
The presence of thrombosis in  superior sagittal sinus and lateral sinus is 
not  associated  with  poor  outcome.  Whereas  straight  sinus  thrombosis  is 
associated significantly with poor outcome.
Ferro Canhao et al predicted a poor outcome with deep cerebral venous 
thrombosis. Deep Cerebral venous thrombosis is associated with thalamic and 
deep grey matter  and brainstem lesion.  So it  is  associated frequently with 
altered  sensorium and poor  Glascow coma scale  .  This  explains  the  poor 
outcome of patients with deep cerebral venous thrombosis.
Straight sinus thrombosis is seen in 4 patients in CT whereas in MRI in 
10 patients showing the greater pickup rate in MRI.
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Detection  of deep T2 hyperintense lesions has a poor outcome. In our 
study 9 out of 48 had deep T2 hyperintense lesions. Out of this 9 patients 8 
(88.8%) had poor outcome. In our study of the 9 poor outcome  patients  8 
(88.8%)  had  deep  T2  hyperintense lesions. So deep hyperintense lesion are 
sensitive and specific in predicting poor outcome.
Edema can be vasogenic or  cytotoxic edema. Cytotoxic edema is due to 
entry of water into the cells due to decreased ATP. This in course leads to cell 
death and infarction. So cytotoxic edema is the precursor of infarction. Since 
intracellular macromolecules and membranous organelles interact and bound 
with the intracellular water molecules, these protons have restricted diffusion.
This can be detected by using DWI in which separate diffusion gradients 
of varying strengths are given and the signal loss due to diffusion is measured.
In DWI free protons have decreased signals in higher gradients, whereas 
bound or restricted protons give higher signals or hyperintense. It  is to be 
remembered  that cytotoxic edema is only the precursor of infarction.
In  our  study  group  all  the  9  patients  who  had  poor  outcome  had 
restricted diffusion. Four  patients  who  had  restricted  diffusion  had  no 
residual CNS deficit.
In  other  words  all  poor  outcome patients  had diffusion restriction i.e 
100%  sensitive  in  predicting  outcome.  But  4  patients  who  had  restricted 
diffusion recovered completely i.e it is less specific in predicting the outcome.
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According  to  Mullins  et  al three  out  of  14  lesions  had  restricted 
diffusion but resolved in follow-up and 4 out of 14 had restricted  diffusion 
and persisted.
In our study against the above study 9 out of 30 had restricted diffusion 
and had poor out come and 4 out  of 30 had restricted diffusion and with good 
outcome.
Reversible DWI restricted lesions are shown in the studies of Ducreax,  
Appenhium et al, Sarma D, Farbe et al.
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SUMMARY
In  our  prospective  cohort  study  of  48  patients  with  cerebral  venous 
thrombosis diagnosed by MRI and MRV it can be summarised as follows.
1. Cerebral  venous  thrombosis  incidence  is  not  uncommon  in 
males.
2. Puerperium is a risk factor for cerebral venous thrombosis.
3. Presence of altered sensorium  and focal neurological deficits 
at admission predicts poor outcome.
4. CT  is  a  good  first  line  investigation  for  Cerebral  venous 
thrombosis.
5. Presence  of  intraparenchymal  hemorrhage  and  parenchymal 
hypodense lesions in CT are associated with poor outcome.
6. MRI features of poor outcome are
(i) Presence of intraparenchymal hemorrhage 
(ii) Straight sinus thrombosis
(iii) Presence of deep  parenchymal T2 hyperintense lesion.
(iv) Restriction of diffusion.
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CONCLUSION
In our study of cerebral venous thrombosis it can be concluded that MRI 
is  useful  in  prognostic  evaluation.  Diffusion  weighted  images  are  good 
prognostic tools. Restriction of diffusion is a poor prognostic indicator.
MRI  features  of  deep  T2  hyperintense  lesions,  intraparenchymal 
hemorrhage and straight sinus thrombosis are poor prognostic factors.
Presence of altered sensorium and focal neurological deficit at admission 
and CT findings  of  parenchymal  hemorrhage  and parenchymal  hypodense 
lesions also predict poor outcome.
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PROFORMA
Name: Age: I.P.No:
> 25 Yrs
25-35 Yrs
35-45 Yrs
>45 Yrs
Sex :          M/F Address:
Puerperium
Others
Clinical features
Headache : Yes / No
Seizure : Yes / No
 Focal / Generalised
Altered sensorium : Yes / No
Coma : Yes / No
Focal Neurol Deficit : Yes / No
Hemiparesis / Monoparesis / Paraparesis / 
Dysphasia / Blindness / CN deficit / 
Others.
Investigations
CT - Hemorrhage : Yes / No
Hypodensity : Yes / No
Thrombosis - SSS : Yes / No
LS : Yes / No
STS : Yes / No
MRI Hemorrhage : Yes / No
Thrombosis SSS : Yes / No
LS : Yes / No
STS : Yes / No
Cort.Vein : Yes / No
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T2 Hyper intensity : Yes / No
Superficial : Yes / No
Deep : Yes / No
Diffusion Restriction : Yes / No
Treatment
Heparin : Yes / No
Oral Anticoagulants : Yes / No
Antiepileptic : Yes / No
Antiedema : Yes / No
Surgical decompression : Yes / No
8 Weeks Follow up
Death : Yes / No
Focal Neurol deficit : Yes / No
Hemiparesis / Monoparesis / 
Paraparesis / Dysphasia / Blindness 
/ CN deficit / Others.
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ANNEXURE
ABBREVIATION
CVT - Cerebral Venous Sinus Thrombosis
SSS - Superior Sagittal Sinus
LS - Lateral Sinus
STS - Straight Sinus
FSE - Fast Spin Echo
GRE - Gradient Recalled Echo
TOF - Time of Flight
MRV - Magnetic Resonance Venogram
MRA - Magnetic Resonance Angiogram
TR - Time for Repitition
TE - Time to Echo
T1WI - T1 weighted image
ICA - Internal Carotid Artery
FLAIR - Fluid Attenuated Inversion Recovery Sequence
NECT - Non Enhanced Computed Tomography 
CECT - Contrast  Enhanced Computed Tomography 
MDCT - Multi Detector Computed Tomography
DSA - Digital Subtraction Angiography
DWI - Diffusion Weighted Images
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KEY TO MASTER CHART
Sex - 0 Female
1 Male
Puer - Puerperium
HA - Headache
Alt Sen - Altered Sensorium
Def - Focal neurological deficit
HGE - Hemorrhage
SSS T - Superior Sagittal Sinus Thrombosis
LS T - Lateral Sinus Thrombosis
STS T - Straight Sinus Thrombosis
Hypo - Hypodensity
Cort VT - Cortical Vein Thrombosis
T2 Super - T2 Superficial hyper intensity
T2 Deep - T2 Deep hyper intensity
Diff Res - Diffusion restriction
0 - Absent
1 - Present
Followup - 0 - Normal
1 - Focal neurological deficit
2 - Death
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